NSUN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.150200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.319200E-01
Normal-vs-Stage2
6.094600E-01
Normal-vs-Stage3
1.135200E-01
Normal-vs-Stage4
3.027000E-01
Stage1-vs-Stage2
3.892600E-01
Stage1-vs-Stage3
6.561700E-02
Stage1-vs-Stage4
1.849230E-01
Stage2-vs-Stage3
1.108420E-01
Stage2-vs-Stage4
2.715300E-03
Stage3-vs-Stage4
3.813600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.880400E-01
Normal-vs-AfricanAmerican
9.218000E-01
Normal-vs-Asian
4.719600E-01
Caucasian-vs-AfricanAmerican
3.543600E-01
Caucasian-vs-Asian
5.576200E-01
AfricanAmerican-vs-Asian
2.942200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.208000E-01
Normal-vs-Female
6.144600E-01
Male-vs-Female
8.664000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.154200E-01
Normal-vs-Age(41-60Yrs)
8.820600E-01
Normal-vs-Age(61-80Yrs)
5.250000E-01
Normal-vs-Age(81-100Yrs)
4.081000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.695600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.134600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.131000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.045750E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.055600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.100800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.679000E-01
Normal-vs-Daily Drinker
4.911400E-01
Normal-vs-Weekly Drinker
4.324800E-01
Normal-vs-Occasional Drinker
9.899000E-01
Normal-vs-Social Drinker
5.606600E-01
Non Drinker-vs-Daily Drinker
9.243400E-01
Non Drinker-vs-Weekly Drinker
9.151400E-01
Non Drinker-vs-Occasional Drinker
1.016410E-01
Non Drinker-vs-Social Drinker
6.449800E-01
Daily Drinker-vs-Weekly Drinker
8.729600E-01
Daily Drinker-vs-Occasional Drinker
1.927420E-01
Daily Drinker-vs-Social Drinker
7.592000E-01
Weekly Drinker-vs-Occasional Drinker
1.874580E-01
Weekly Drinker-vs-Social Drinker
6.558200E-01
Occasional Drinker-vs-Social Drinker
3.365800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.552500E-02
Normal-vs-Grade 2
5.077700E-03
Normal-vs-Grade 3
6.483600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.175300E-03
Grade 1-vs-Grade 3
1.126380E-02
Grade 1-vs-Grade 4
5.552500E-02
Grade 2-vs-Grade 3
8.784000E-01
Grade 2-vs-Grade 4
5.077700E-03
Grade 3-vs-Grade 4
6.483600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.602000E-01
Normal-vs-NonDiabetic
5.091600E-01
Diabetic-vs-NonDiabetic
4.962800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.850000E-01
Normal-vs-NoPancreatitis
5.093800E-01
Pancreatitis-vs-NoPancreatitis
3.033800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.835000E-01
Normal-vs-N1
6.313800E-01
N0-vs-N1
8.320800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.417400E-01
Normal-vs-TP53-NonMutant
5.443000E-01
TP53-Mutant-vs-TP53-NonMutant
6.276900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
